Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 3 (2006), Issue 8 (August)

1. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin.
   J Pineal Res, 41(2): 189-93. [Abstract] [Full-text]
2. Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus.
   Fertil Steril, 86(2): 405-10. [Abstract] [Full-text]
3. Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.
   J Intern Med, 260(2): 125-33. [Abstract] [Full-text]
4. Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children.
   Crit Care Med, 34(8): 2217-23. [Abstract] [Full-text]
5. Modulation of the flux patterns in carbohydrate metabolism in the livers of streptozoticin-induced diabetic rats by dietary caloric restriction.
   Pharmacol Res, 54(3): 172-80. [Abstract] [Full-text]
6. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
   N Engl J Med, 355(5): 467-77. [Abstract] [Full-text]
7. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
   N Engl J Med, 355(5): 456-66. [Abstract] [Full-text]
8. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice.
   Life Sci, 79(12): 1207-13. [Abstract] [Full-text]
9. High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes.
   Life Sci, 79(12): 1194-202. [Abstract] [Full-text]
10. Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study.
    J Urol, 176(3): 1081-5; discussion 1085. [Abstract] [Full-text]
11. Mother and adolescent representations of illness ownership and stressful events surrounding diabetes.
    J Pediatr Psychol, 31(8): 818-27. [Abstract] [Full-text]
12. Gender differences in adherence and metabolic control in urban youth with poorly controlled type 1 diabetes: the mediating role of mental health symptoms.
    J Pediatr Psychol, 31(8): 793-802. [Abstract] [Full-text]
13. Predictors of youth diabetes care behaviors and metabolic control: a structural equation modeling approach.
    J Pediatr Psychol, 31(8): 770-84. [Abstract] [Full-text]
14. Brief report: glycemic control, quality of life, and school experiences among students with diabetes.
    J Pediatr Psychol, 31(8): 764-9. [Abstract] [Full-text]
15. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Circulation, 114(6): 597-605. [Abstract] [Full-text]
16. Vitamin D receptor polymorphisms and diseases.
    Clin Chim Acta, 371(1): 1-12. [Abstract] [Full-text]
17. Temporal diabetes- and diuresis-induced remodeling of the urinary bladder in the rat.
    Am J Physiol Regul Integr Comp Physiol, 291(3): R837-43. [Abstract] [Full-text]
18. Restoring depressed HERG K+ channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits.
    Am J Physiol Heart Circ Physiol, 291(3): H1446-55. [Abstract] [Full-text]
19. Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus.
    Am J Physiol Renal Physiol, 291(3): F694-701. [Abstract] [Full-text]
20. Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with Type 2 diabetes.
    Am J Physiol Heart Circ Physiol, 291(3): H1193-9. [Abstract] [Full-text]
21. Metabolic and skeletal complications of HIV infection: the price of success.
    JAMA, 296(7): 844-54. [Abstract] [Full-text]
22. Effect of P2X7 receptor activation on the retinal blood velocity of diabetic rabbits.
    Arch Ophthalmol, 124(8): 1143-9. [Abstract] [Full-text]
23. An automated microaneurysm detector as a tool for identification of diabetic retinopathy in rural optometric practice.
    Clin Exp Optom, 89(5): 299-305. [Abstract] [Full-text]
24. Analysis of coding variants in the betacellulin gene in type 2 diabetes and insulin secretion in African American subjects.
    BMC Med Genet, 7: 62. [Abstract] [Full-text]
25. Keystone meeting summary: 'Adipogenesis, obesity, and inflammation' and 'Diabetes mellitus and the control of cellular energy metabolism, ' January 21-26, 2006, Vancouver, Canada.
    Genes Dev, 20(16): 2193-201. [Abstract] [Full-text]
26. Peroxisome proliferator-activated receptor alpha deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: Modulation of T cell differentiation.
    Endocrinology, 147(9): 4410-8. [Abstract] [Full-text]
27. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Endocrinology, 147(9): 4252-62. [Abstract] [Full-text]
28. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
    Am J Physiol Endocrinol Metab, 291(3): E675-82. [Abstract] [Full-text]
29. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
    Toxicol Appl Pharmacol, 215(2): 146-57. [Abstract] [Full-text]
30. Concomitant impairment in endothelial function and neural cardiovascular regulation in offspring of type 2 diabetic subjects.
    Hypertension, 48(3): 418-23. [Abstract] [Full-text]
31. Diabetes and hyperglycemia: strict glycemic control.
    Crit Care Med, 34(9): S291-300. [Abstract] [Full-text]
32. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy.
    Arterioscler Thromb Vasc Biol, 26(9): 2140-6. [Abstract] [Full-text]
33. Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up.
    J Intern Med, 260(3): 272-80. [Abstract] [Full-text]
34. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.
    J Intern Med, 260(3): 263-71. [Abstract] [Full-text]
35. Diabetes care in the San Francisco County Jail.
    Am J Public Health, 96(9): 1571-4. [Abstract] [Full-text]
36. Trends in hospitalization and sociodemographic factors in diabetic and nondiabetic populations in Germany: national health survey, 1990-1992 and 1998.
    Am J Public Health, 96(9): 1656-61. [Abstract] [Full-text]
37. Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus.
    Am J Public Health, 96(9): 1643-8. [Abstract] [Full-text]
38. The answer to diabetes prevention: science, surgery, service delivery, or social policy?
    Am J Public Health, 96(9): 1562-9. [Abstract] [Full-text]
39. Understanding the determinants of health for people with type 2 diabetes.
    Am J Public Health, 96(9): 1649-55. [Abstract] [Full-text]
40. Education and diabetes in a racially and ethnically diverse population.
    Am J Public Health, 96(9): 1637-42. [Abstract] [Full-text]
41. Comparison of functional status after coronary artery bypass grafting in patients with and without diabetes mellitus.
    Am J Cardiol, 98(5): 619-23. [Abstract] [Full-text]
42. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes.
    Am Heart J, 152(3): 599-605. [Abstract] [Full-text]
43. Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptide.
    Biochem Pharmacol, 72(6): 719-28. [Abstract] [Full-text]
44. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.
    J Lipid Res, 47(9): 2028-41. [Abstract] [Full-text]
45. Pharmacological targeting of adipocytes/fat metabolism for treatment of obesity and diabetes.
    Mol Pharmacol, 70(3): 779-85. [Abstract] [Full-text]
46. Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.
    Kidney Int, 70(5): 882-91. [Abstract] [Full-text]
47. Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema.
    Br J Ophthalmol, 90(9): 1137-41. [Abstract] [Full-text]
48. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.
    Science, 313(5790): 1137-40. [Abstract] [Full-text]
49. Diabetes mellitus reduces the antiarrhythmic effect of ion channel blockers.
    Anesth Analg, 103(3): 545-50. [Abstract] [Full-text]
50. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
    Am J Cardiol, 98(5): 14J-18J. [Abstract] [Full-text]
51. alpha-lipoic acid corrects late-phase supernormal retinal oxygenation response in experimental diabetic retinopathy.
    Invest Ophthalmol Vis Sci, 47(9): 4077-82. [Abstract] [Full-text]
52. P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus.
    Nutr Metab Cardiovasc Dis, 16(6): 418-25. [Abstract] [Full-text]
53. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
    Nutr Metab Cardiovasc Dis, 16(6): 395-404. [Abstract] [Full-text]
54. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
    Am J Ophthalmol, 142(3): 501-3. [Abstract] [Full-text]
55. Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy.
    Am J Ophthalmol, 142(3): 488-90. [Abstract] [Full-text]
56. Optical coherence tomographic patterns of diabetic macular edema.
    Am J Ophthalmol, 142(3): 405-12. [Abstract] [Full-text]
57. Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats.
    Toxicol Lett, 166(1): 27-36. [Abstract] [Full-text]
58. A tactile stimulus applied to the leg improves postural stability in young, old and neuropathic subjects.
    Neurosci Lett, 406(1): 23-6. [Abstract] [Full-text]
59. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.
    Mol Immunol, 44(4): 648-55. [Abstract] [Full-text]
60. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.
    Clin Infect Dis, 43(7): 848-54. [Abstract] [Full-text]
61. Mechanistic insights into targeting T cell membrane proteinase to promote islet beta-cell rejuvenation in type 1 diabetes.
    FASEB J, 20(11): 1793-801. [Abstract] [Full-text]
62. Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes.
    Expert Opin Emerg Drugs, 11(3): 525-39. [Abstract] [Full-text]
63. Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis.
    Expert Opin Emerg Drugs, 11(3): 379-401. [Abstract] [Full-text]
64. Lack of concordance between the 75-g and 100-g glucose load tests for the diagnosis of gestational diabetes mellitus.
    Clin Chem, 52(9): 1679-84. [Abstract] [Full-text]
65. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
    Stroke, 37(9): 2420-7. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.